InfuSystems Holdings Inc
$ 12.49
5.22%
07 Aug - close price
- Market Cap 252,069,000 USD
- Current Price $ 12.49
- High / Low $ 12.49 / 11.59
- Stock P/E 31.23
- Book Value 2.97
- EPS 0.40
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.07 %
- ROE 0.15 %
- 52 Week High 12.97
- 52 Week Low 7.29
About
InfuSystem Holdings, Inc., provides infusion pumps and related products and services in the United States and Canada. The company is headquartered in Rochester Hills, Michigan.
Analyst Target Price
$17.62
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-04 | 2026-05-07 | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-08 | 2025-03-04 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-14 | 2023-11-07 |
| Reported EPS | 0.15 | 0.05 | 0.1 | 0.15 | 0.15 | 0.1 | 0.0705 | 0.13 | 0.03 | -0.05 | 0.0033 | 0.07 |
| Estimated EPS | 0.12 | 0.03 | 0.07 | 0.05 | 0.04 | -0.03 | 0.06 | 0.05 | 0.04 | 0.01 | 0.02 | 0.09 |
| Surprise | 0.03 | 0.02 | 0.03 | 0.1 | 0.11 | 0.13 | 0.0105 | 0.08 | -0.01 | -0.06 | -0.0167 | -0.02 |
| Surprise Percentage | 25% | 66.6667% | 42.8571% | 200% | 275% | 433.3333% | 17.5% | 160% | -25% | -600% | -83.5% | -22.2222% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: INFU
2026-08-06 00:41:23
InfuSystem Holdings, Inc. reported record quarterly revenue and improved adjusted EBITDA, driven by strong oncology and wound care segments, despite headwinds from a restructured GE Healthcare contract and increased operating expenses. The company reaffirmed its 2026 revenue growth guidance and aims for continued margin expansion, positioning itself as a disciplined healthcare services provider focused on strategic growth and conservative leverage.
2026-08-05 13:43:01
B. Riley has increased its target price for InfuSystem Holdings Inc (INFU.A) shares from $12 to $20. This financial adjustment reflects an updated outlook from the analyst firm. The article, published by Reuters, indicates this change occurred on August 5, 2026, at 12:48 PM.
2026-08-04 19:11:59
InfuSystem Holdings, Inc (INFU) reported its second-quarter 2026 results, with revenue reaching $36.93 million and diluted EPS at $0.15. This reflects a modest top-line growth and increased profitability compared to the prior year. Key highlights include a 15% rise in Patient Services revenue, driven by oncology and wound care, and an improved channel mix despite a decline in Device Solutions revenue due to contract restructuring.
2026-08-04 17:11:59
InfuSystem Holdings reported strong Q2 2026 results, surpassing Wall Street expectations for both profit and revenue. The company achieved record quarterly sales of $36.9 million and increased its adjusted EPS to $0.15, leading to a 14.3% jump in premarket shares. Growth was primarily driven by its patient services segment, especially oncology and wound care, despite a revenue decline in biomedical services due to a contract restructuring.
2026-08-04 11:40:20
InfuSystem Holdings, Inc. reported strong second-quarter 2026 financial results, with diluted earnings per share of $0.15, exceeding analyst estimates by 36.4%. The company's revenue reached $36.9 million, a 2.6% increase year-over-year, driven by robust demand in its Patient Services segment. InfuSystem's net income for the quarter was $3.2 million, and analyst sentiment remains largely positive.
2026-08-02 10:09:48
This article lists several ETFs that hold InfuSystem Holdings, Inc. (INFU) stocks, providing details such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, and 3-year NAV total return. The ETFs cover various investment strategies including small-cap value, growth, micro-cap, and multifactor approaches. It highlights how these funds can make investing in INFU more accessible and offer diversified opportunities with lower risk.
